Rightway, a NYC-based healthcare technology and services company innovating care navigation and pharmacy benefits, raised $100m in Series C financing at a valuation of $1.1 billion.
The round was led by Khosla Ventures, with participation from Thrive Capital, Tiger Global Management, and other existing investors. In conjunction with the funding, Samir Kaul, founding general partner at Khosla Ventures, will be joining Rightway’s board of directors.
The company intends to use the funds to expand its presence in the employer market and accelerate its advancement across health plans, third-party administrators and other strategic channels, advance the build of RightwayRx.
Led by Jordan Feldman, CEO, Rightway is a technology and services company providing care navigation and pharmacy benefits solutions delivered through a consumer-centric app that pairs every member with a live, clinician-led care team. By combining expert, human guidance with intuitive technology, the company drives members towards the best care and medication at the best price while eliminating wasteful and preventable spend. Rightway currently partners with over 850 employer clients.
FinSMEs
30/03/2021